Open Access. Powered by Scholars. Published by Universities.®

Medicine and Health Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

PDF

Electronic Thesis and Dissertation Repository

Theses/Dissertations

2014

Cancer

Articles 1 - 2 of 2

Full-Text Articles in Medicine and Health Sciences

Women's Stories Of Breast Cancer: Sharing Information Through Youtube Video Blogs, Jenna Kressler Jun 2014

Women's Stories Of Breast Cancer: Sharing Information Through Youtube Video Blogs, Jenna Kressler

Electronic Thesis and Dissertation Repository

Breast cancer is one of the most prevalent chronic diseases among North American women. Individuals need accessible and reliable health information for self-care and self-health promotion. Increasingly, individuals are contributing to and accessing information about cancer, using interactive online resources such as YouTube. The purpose of this research was to investigate the personal YouTube video blogs of women with breast cancer and their portrayed messages. This study used a narrative inquiry to examine the video blogs of four women with breast cancer. The women talked about having cancer as a transformative experience. Information about breast cancer from healthcare providers was …


Indoleamine 2,3-Dioxygenase Confers Resistance To Chemotherapy And Γ Radiation To Cancer Cells, Independent Of Direct Immune Involvement, Saman Maleki Vareki Mar 2014

Indoleamine 2,3-Dioxygenase Confers Resistance To Chemotherapy And Γ Radiation To Cancer Cells, Independent Of Direct Immune Involvement, Saman Maleki Vareki

Electronic Thesis and Dissertation Repository

Indoleamine 2,3-dioxygenase-1 (IDO) is an immunosuppressive molecule expressed by most human tumours. IDO levels correlate with poor prognosis in cancer patients and IDO inhibitors are under investigation to enhance endogenous anticancer immunosurveillance. Little is known regarding the immune-independent functions of IDO relevant to cancer therapy. In this thesis I show, for the first time, that IDO mediates human tumour cell resistance, in a cell-autonomous fashion, to single and combination treatment with a diverse group of chemotherapy drugs and g radiation. These drugs include a PARP inhibitor (olaparib), a DNA cross-linking agent (cisplatin), a folate antimetabolite (pemetrexed), a nucleoside analogue (gemcitabine), …